Clinical significance of signal regulatory protein alpha (SIRPα) expression in esophageal squamous cell carcinoma

Naomichi Koga, Qingjiang Hu, Akihiro Sakai, Kazuki Takada, Ryota Nakanishi, Yuichi Hisamatsu, Koji Ando, Yasue Kimura, Eiji Oki, Yoshinao Oda, Masaki Mori

Research output: Contribution to journalArticlepeer-review

Abstract

Signal regulatory protein alpha (SIRPα) is a type I transmembrane protein that inhibits macrophage phagocytosis of tumor cells upon interaction with CD47, and the CD47-SIRPα pathway acts as an immune checkpoint factor in cancers. This study aims to clarify the clinical significance of SIRPα expression in esophageal squamous cell carcinoma (ESCC). First, we assessed SIRPα expression using RNA sequencing data of 95 ESCC tissues from The Cancer Genome Atlas (TCGA) and immunohistochemical analytic data from our cohort of 131 patients with ESCC. Next, we investigated the correlation of SIRPα expression with clinicopathological factors, patient survival, infiltration of tumor immune cells, and expression of programmed cell death-ligand 1 (PD-L1). Overall survival was significantly poorer with high SIRPα expression than with low expression in both TCGA and our patient cohort (P <.001 and P =.027, respectively). High SIRPα expression was associated with greater depth of tumor invasion (P =.0017). Expression of SIRPα was also significantly correlated with the tumor infiltration of M1 macrophages, M2 macrophages, CD8+ T cells, and PD-L1 expression (P <.001, P <.001, P =.03, and P <.001, respectively). Moreover, patients with SIRPα/PD-L1 coexpression tended to have a worse prognosis than patients with expression of either protein alone or neither. Taken together, SIRPα indicates poor prognosis in ESCC, possibly through inhibiting macrophage phagocytosis of tumor cells and inducing suppression of antitumor immunity. Signal regulatory protein alpha should be considered as a potential therapeutic target in ESCC, especially if combined with PD-1-PD-L1 blockade.

Original languageEnglish
Pages (from-to)3018-3028
Number of pages11
JournalCancer Science
Volume112
Issue number8
DOIs
Publication statusPublished - Aug 2021

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Clinical significance of signal regulatory protein alpha (SIRPα) expression in esophageal squamous cell carcinoma'. Together they form a unique fingerprint.

Cite this